A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity LONDON, June 15, 2022 (GLOBE NEWSWIRE) -- With over 460 million global cases thus far, 6 million of which have resulted in death, the COVID-19 pandemic from SARS-CoV-2 proved to be a dire health...

Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2 OTTAWA, Ontario, Oct. 26, 2021 (GLOBE NEWSWIRE) -- After more than one year supporting the Canadian government, NGOs, and corporations in the fight against COVID-19, following the authorization...